Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 4, 2007, Pages 491-494

  DiNubile, Mark J ^a   Friedland, Ian R ^a   Chan, Christina Y ^a   Motyl, Mary R ^a   Giezek, Hilde ^a   McCarroll, Kathleen ^a   Shivaprakash, Malathi ^a   Quinn, John P ^b   Weinstein, Robert A ^b   Chow, Joseph W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

Bowel flora; Ertapenem; Intra abdominal infection; OASIS; Vancomycin resistant enterococci

Indexed keywords

CEFTRIAXONE; ERTAPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTESTINES; MALE; MIDDLE AGED; VANCOMYCIN RESISTANCE;

EID: 34547567196     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.03.016     Document Type: Article

References (22)

1. Bhalla A., Pultz N.J., Ray A.J., Ray A.J., Hoyen C.K., Eckstein E.C., and Donskey C.J. Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect. Control. Hosp. Epidemiol. 24 (2003) 644-649
2. Cavallaro V., Catania V., Bonaccorso R., Bonaccorso R., Mazzone S., Speciale A., Di Marco R., Blandino G., and Caccamo F. Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery. J. Chemother. 4 (1992) 82-87
3. D'Agata E.M., Gautam S., Green W.K., and Tang Y.W. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin. Infect. Dis. 34 (2002) 167-172
4. Dela Pena A.S., Asperger W., Kockerling F., Raz R., Kafka R., Warren B., Shivaprakash M., Vrijens F., Giezek H., DiNubile M.J., and Chan C.Y. Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intraabdominal infections requiring surgical intervention. J. Gastro. Surg. 10 (2006) 567-574
5. DiNubile M.J., Chow J.W., Satishchandran V., Polis A., Motyl M.R., Abramson M.A., and Teppler H. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. Antimicrob. Agents. Chemother. 49 (2005) 3217-3221
6. Donskey C.J. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39 (2004) 219-226
7. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A., Hujer A.M., Hutton-Thomas R.A., Whalen C.C., Bonomo R.A., and Rice L.B. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343 (2000) 1925-1932
8. Guggenbichler J.P., Allerberger F.J., and Dierich M. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy. Padiatr. Padol. 21 (1986) 335-342
9. Harbarth S., Cosgrove S., and Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob. Agents. Chemother. 46 (2002) 1619-1628
10. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342 (2000) 710-721
11. Navarro Jr. N.S., Campos M.I., Alvarado R., Quintero N., Branicki F.J., Wei J., Shivaprakash M., Brijens F., Giezek H., Chan C.Y., and DiNubile M.J. Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections. Internat. J. Surg. 3 (2005) 25-34
12. Ostrowsky B.E., Trick W.E., Sohn A.H., Quirk S.B., Holt S., Carson L.A., Hill B.C., Arduino M.J., Kuehnert M.J., and Jarvis W.R. Control of vancomycin-resistant enterococcus in health care facilities in a region. N. Engl. J. Med. 344 (2001) 1427-1433
13. Ostrowsky B.E., Venkataraman L., D'Agata E.M., Gold H.S., DeGirolami P.C., and Samore M.H. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch. Intern. Med. 159 (1999) 1467-1472
14. Paterson D.L. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis. 38 suppl 4 (2004) 341-345
15. Pletz M.W., Rau M., Bulitta J., De Roux A., Burkhardt O., Kruse G., Kurowski M., Nord C.E., and Lode H. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob. Agents Chemother. 48 (2004) 3765-3772
16. Safdar N., and Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136 (2002) 834-844
17. Solomkin J.S., Yellin A.E., Rotstein O.D., Christou N.V., Dellinger E.P., Tellado J.M., Malafaia O., Fernandez A., Choe K.A., Carides A., Satishchandran V., and Teppler H. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind randomized comparative phase III trial. Ann. Surg. 237 (2003) 235-245
18. Stiefel U., Paterson D.L., Pultz N.J., Gordon S.M., Aron D.C., and Donskey C.J. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect. Control. Hosp. Epidemiol. 25 (2004) 380-383
19. Stiefel U., Pultz N.J., Helfand M.S., and Donskey C.J. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect. Control. Hosp. Epidemiol. 25 (2004) 373-379
20. Stiefel U., Pultz N.J., and Donskey C.J. Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrob. Agents Chemother. 51 (2007) 372-375
21. Weinstein J.W., Tallapragada S., Farrel P., and Dembry L.M. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. J. Clin. Microbiol. 34 (1996) 210-212
22. Yellin A.E., Hassett J.M., Fernandez A., Geib J., Adeyi B., Woods G.L., and Teppler H. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int. J. Antimicrob. Agents. 20 (2002) 165-173